Published in J Neuroimmune Pharmacol on December 13, 2016
A specific amyloid-beta protein assembly in the brain impairs memory. Nature (2006) 16.19
Pathways towards and away from Alzheimer's disease. Nature (2004) 8.72
The molecular pathology of Alzheimer's disease. Neuron (1991) 8.21
Analysis of microarray data using Z score transformation. J Mol Diagn (2003) 6.82
Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci (2006) 6.52
Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron (2005) 6.20
Alzheimer mechanisms and therapeutic strategies. Cell (2012) 5.24
Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A (2006) 3.98
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging (2003) 3.83
Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Neuron (2006) 2.88
Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc Natl Acad Sci U S A (2003) 2.83
Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits. Brain (2011) 2.76
Exposing rats to a predator impairs spatial working memory in the radial arm water maze. Hippocampus (1999) 1.95
Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc Natl Acad Sci U S A (1990) 1.66
Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol (2012) 1.64
Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res (2001) 1.59
Cathepsin B. Int J Biochem Cell Biol (1997) 1.59
Proteases in brain tumour progression. Acta Neurochir (Wien) (2003) 1.48
Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. J Biol Chem (2008) 1.45
At the end of the autophagic road: an emerging understanding of lysosomal functions in autophagy. Trends Biochem Sci (2013) 1.44
Membrane trafficking pathways in Alzheimer's disease. Traffic (2012) 1.39
Immunotherapy for Alzheimer's disease: hoops and hurdles. Mol Neurodegener (2013) 1.35
Abeta oligomer-mediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanisms. J Neurosci (2007) 1.28
CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APP+PS1 bigenic mice. FASEB J (2010) 1.25
Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin. Brain Res (1990) 1.18
Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models. PLoS One (2011) 1.17
Cathepsin B: multiple roles in cancer. Proteomics Clin Appl (2014) 1.03
Genetic cathepsin B deficiency reduces beta-amyloid in transgenic mice expressing human wild-type amyloid precursor protein. Biochem Biophys Res Commun (2009) 1.00
Autophagy: a double-edged sword in Alzheimer's disease. J Biosci (2012) 1.00
FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders. Proc Natl Acad Sci U S A (2011) 1.00
AAV1/2-mediated CNS gene delivery of dominant-negative CCL2 mutant suppresses gliosis, beta-amyloidosis, and learning impairment of APP/PS1 mice. Mol Ther (2009) 0.98
Cathepsin B degrades amyloid-β in mice expressing wild-type human amyloid precursor protein. J Biol Chem (2012) 0.97
The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity. J Alzheimers Dis (2011) 0.97
Cysteine protease inhibitors effectively reduce in vivo levels of brain beta-amyloid related to Alzheimer's disease. Biol Chem (2007) 0.96
Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease? Curr Opin Psychiatry (2014) 0.96
The peptidases of Trypanosoma cruzi: digestive enzymes, virulence factors, and mediators of autophagy and programmed cell death. Biochim Biophys Acta (2011) 0.93
Endothelin-converting enzymes degrade intracellular β-amyloid produced within the endosomal/lysosomal pathway and autophagosomes. J Biol Chem (2013) 0.93
Measurements of vector-derived neurotrophic factor and green fluorescent protein levels in the brain. Methods (2002) 0.92
Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages. Retrovirology (2015) 0.92
Quantitative proteomics by SWATH-MS reveals altered expression of nucleic acid binding and regulatory proteins in HIV-1-infected macrophages. J Proteome Res (2014) 0.89
Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence. J Alzheimers Dis (2012) 0.88
miR128 up-regulation correlates with impaired amyloid β(1-42) degradation in monocytes from patients with sporadic Alzheimer's disease. Neurobiol Aging (2013) 0.88
CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease. Neurobiol Aging (2012) 0.85
Intracellular aggregation of human stefin B: confocal and electron microscopy study. Biol Cell (2010) 0.83
Presenilin-1 familial Alzheimer's disease mutation alters hippocampal neurogenesis and memory function in CCL2 null mice. Brain Behav Immun (2015) 0.78
The cross-road between the mechanisms of protein folding and aggregation; study of human stefin B and its H75W mutant. Biochem Biophys Res Commun (2011) 0.77
AAV2/1 CD74 Gene Transfer Reduces β-amyloidosis and Improves Learning and Memory in a Mouse Model of Alzheimer's Disease. Mol Ther (2015) 0.77